Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01635855 · ClinicalTrials.gov registry record · Phase 4
Belotero Post Approval Study
A Phase 4 study, sponsored by Merz North America.
- Completed
- Registry status
- Phase 4
- Development phase
- 117
- Enrollment target
NCT01635855 is a Phase 4 study that has completed, run by Merz North America. The registered enrollment target is 117 participants.
The verdict
NCT01635855, a Phase 4 study, has completed, sponsored by Merz North America.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 117 participants
- Enrollment target
Study Summary
A prospective, open-label 1-month post-approval study to evaluate the short term safety of Belotero® Balance in the re-treatment of nasolabial folds.
Interventions
- DEVICE Belotero®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2012-06 |
| Est. Completion | 2012-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01635855
The ClinicalTrials.gov registry entry for NCT01635855 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merz North America, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Belotero® is the first listed.
NCT01635855 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01635855 about?
NCT01635855 is a clinical study titled "Belotero Post Approval Study". A prospective, open-label 1-month post-approval study to evaluate the short term safety of Belotero® Balance in the re-treatment of nasolabial folds.
What is the current status of trial NCT01635855?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 117 participants. The study started on 2012-06. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01635855?
The interventions under investigation include: Belotero® (DEVICE).
Who is sponsoring clinical trial NCT01635855?
This trial is sponsored by Merz North America, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.